{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:00:45Z","timestamp":1784725245803,"version":"3.55.0"},"reference-count":215,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41571-026-01152-z","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T10:59:50Z","timestamp":1777978790000},"page":"582-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The transformative role of SBRT in the management of spinal metastases"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-4726","authenticated-orcid":false,"given":"K. Liang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9975-4379","authenticated-orcid":false,"given":"Pejman Jabehdar","family":"Maralani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Detsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Dinakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Larouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jetan","family":"Badhiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna J.","family":"Jerzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Singnurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari","family":"Whyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ruschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7991-8970","authenticated-orcid":false,"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"1152_CR1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20190211","volume":"92","author":"M Mossa-Basha","year":"2019","unstructured":"Mossa-Basha, M. et al. Spinal metastasis: diagnosis, management and follow-up. Br. J. Radiol. 92, 20190211 (2019).","journal-title":"Br. J. Radiol."},{"key":"1152_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00304-x","volume":"3","author":"NL Hudock","year":"2023","unstructured":"Hudock, N. L. et al. Future trends in incidence and long-term survival of metastatic cancer in the United States. Commun. Med. 3, 76 (2023).","journal-title":"Commun. Med."},{"key":"1152_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2400443","volume":"4","author":"D Debieuvre","year":"2025","unstructured":"Debieuvre, D. et al. Survival of patients with lung adenocarcinoma diagnosed in 2000, 2010, and 2020. NEJM Evid. 4, EVIDoa2400443 (2025).","journal-title":"NEJM Evid."},{"key":"1152_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","volume":"126","author":"SE Rich","year":"2018","unstructured":"Rich, S. E. et al. Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiother. Oncol. 126, 547\u2013557 (2018).","journal-title":"Radiother. Oncol."},{"key":"1152_CR5","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/j.ijrobp.2011.06.1980","volume":"82","author":"D Hyde","year":"2012","unstructured":"Hyde, D. et al. Spine stereotactic body radiotherapy utilizing cone-beam CT image-guidance with a robotic couch: intrafraction motion analysis accounting for all six degrees of freedom. Int. J. Radiat. Oncol. Biol. Phys. 82, e555\u2013e562 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR6","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict, S. H. et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med. Phys. 37, 4078\u20134101 (2010).","journal-title":"Med. Phys."},{"key":"1152_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","volume":"24","author":"A Sahgal","year":"2012","unstructured":"Sahgal, A. et al. The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy. Clin. Oncol. 24, 629\u2013639 (2012).","journal-title":"Clin. Oncol."},{"key":"1152_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","volume":"76","author":"L Potters","year":"2010","unstructured":"Potters, L. et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 76, 326\u2013332 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.radonc.2019.06.037","volume":"141","author":"R Chow","year":"2019","unstructured":"Chow, R. et al. Single vs multiple fraction palliative radiation therapy for bone metastases: cumulative meta-analysis. Radiother. Oncol. 141, 56\u201361 (2019).","journal-title":"Radiother. Oncol."},{"key":"1152_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(21)00196-0","volume":"22","author":"A Sahgal","year":"2021","unstructured":"Sahgal, A. et al. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial. Lancet Oncol. 22, 1023\u20131033 (2021).","journal-title":"Lancet Oncol."},{"key":"1152_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ijrobp.2022.05.043","volume":"114","author":"KL Zeng","year":"2022","unstructured":"Zeng, K. L. et al. Mature local control and reirradiation rates comparing spine stereotactic body radiation therapy with conventional palliative external beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 114, 293\u2013300 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR12","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines for central nervous system cancers V.5.2024. NCCN https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cns.pdf (2025)."},{"key":"1152_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109966","volume":"190","author":"M Guckenberger","year":"2024","unstructured":"Guckenberger, M. et al. ESTRO clinical practice guideline: stereotactic body radiotherapy for spine metastases. Radiother. Oncol. 190, 109966 (2024).","journal-title":"Radiother. Oncol."},{"key":"1152_CR14","first-page":"33","volume":"37","author":"F Vilotte","year":"2022","unstructured":"Vilotte, F. et al. Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (French Society of Urological Radiation Oncologists) recommendations using a national two-round modified Delphi survey. Clin. Transl. Radiat. Oncol. 37, 33\u201340 (2022).","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"1152_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.prro.2024.04.018","volume":"14","author":"S Alcorn","year":"2024","unstructured":"Alcorn, S. et al. External beam radiation therapy for palliation of symptomatic bone metastases: an ASTRO clinical practice guideline. Pract. Radiat. Oncol. 14, 377\u2013397 (2024).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.prro.2023.08.001","volume":"13","author":"A Sahgal","year":"2023","unstructured":"Sahgal, A. et al. A Cancer Care Ontario consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiation therapy treatment in Ontario. Pract. Radiat. Oncol. 13, 499\u2013509 (2023).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR17","unstructured":"eviQ. Spinal bone metastases palliative EBRT stereotactic. NSW Government https:\/\/www.eviq.org.au\/radiation-oncology\/palliative\/4098-spinal-bone-metastases-palliative-ebrt-stereo (2025)."},{"key":"1152_CR18","unstructured":"Japanese Society of Medical Oncology (ed.) Clinical Practice Guideline for Bone Metastases revised 2nd edn, 62\u201363 (Nankado, 2022)."},{"key":"1152_CR19","unstructured":"Japanese Society for Radiation Oncology (JASTRO) (ed.). Radiation Therapy Planning Guidelines 449\u2013456 (Kanehara, 2024)."},{"key":"1152_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/jrr\/rraf009","volume":"66","author":"M Saito","year":"2025","unstructured":"Saito, M. et al. A Japanese national survey on IMRT\/SBRT in 2023 by the JASTRO High-Precision External Beam Radiotherapy Group. J. Radiat. Res. 66, 234\u2013252 (2025).","journal-title":"J. Radiat. Res."},{"key":"1152_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3171\/2017.1.SPINE16684","volume":"27","author":"ZA Husain","year":"2017","unstructured":"Husain, Z. A. et al. Stereotactic body radiotherapy for de novo spinal metastases: systematic review. J. Neurosurg. Spine 27, 295\u2013302 (2017).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","volume":"27","author":"S Myrehaug","year":"2017","unstructured":"Myrehaug, S. et al. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J. Neurosurg. Spine 27, 428\u2013435 (2017).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR23","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.prro.2021.10.004","volume":"12","author":"S Faruqi","year":"2022","unstructured":"Faruqi, S. et al. Stereotactic radiosurgery for postoperative spine malignancy: a systematic review and International Stereotactic Radiosurgery Society practice guidelines. Pract. Radiat. Oncol. 12, e65\u2013e78 (2022).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/107327481201900204","volume":"19","author":"J Choi","year":"2012","unstructured":"Choi, J. & Raghavan, M. Diagnostic imaging and image-guided therapy of skeletal metastases. Cancer Control 19, 102\u2013112 (2012).","journal-title":"Cancer Control"},{"key":"1152_CR25","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1470-2045(22)00092-4","volume":"23","author":"D Dearnaley","year":"2022","unstructured":"Dearnaley, D. et al. Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 23, 501\u2013513 (2022).","journal-title":"Lancet Oncol."},{"key":"1152_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12149-020-01474-7","volume":"34","author":"DH Simsek","year":"2020","unstructured":"Simsek, D. H. et al. Does bone scintigraphy still have a role in the era of 68Ga-PSMA PET\/CT in prostate cancer? Ann. Nucl. Med. 34, 476\u2013485 (2020).","journal-title":"Ann. Nucl. Med."},{"key":"1152_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2967\/jnumed.119.234260","volume":"61","author":"GJR Cook","year":"2020","unstructured":"Cook, G. J. R. & Goh, V. Molecular imaging of bone metastases and their response to therapy. J. Nucl. Med. 61, 799\u2013806 (2020).","journal-title":"J. Nucl. Med."},{"key":"1152_CR28","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman, M. S. et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet 395, 1208\u20131216 (2020).","journal-title":"Lancet"},{"key":"1152_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1634\/theoncologist.2012-0293","volume":"18","author":"I Laufer","year":"2013","unstructured":"Laufer, I. et al. The NOMS framework: approach to the treatment of spinal metastatic tumors. Oncologist 18, 744\u2013751 (2013).","journal-title":"Oncologist"},{"key":"1152_CR30","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1017\/S031716710001177X","volume":"38","author":"GR Paton","year":"2011","unstructured":"Paton, G. R., Frangou, E. & Fourney, D. R. Contemporary treatment strategy for spinal metastasis: the \u201cLMNOP\u201d system. Can. J. Neurol. Sci. 38, 396\u2013403 (2011).","journal-title":"Can. J. Neurol. Sci."},{"key":"1152_CR31","doi-asserted-by":"publisher","first-page":"E1221","DOI":"10.1097\/BRS.0b013e3181e16ae2","volume":"35","author":"CG Fisher","year":"2010","unstructured":"Fisher, C. G. et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine 35, E1221\u2013E1229 (2010).","journal-title":"Spine"},{"key":"1152_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/neuonc\/noy047","volume":"20","author":"I Laufer","year":"2018","unstructured":"Laufer, I. et al. Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report. Neuro Oncol. 20, 1215\u20131224 (2018).","journal-title":"Neuro Oncol."},{"key":"1152_CR33","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/j.spinee.2014.03.043","volume":"14","author":"M Huisman","year":"2014","unstructured":"Huisman, M. et al. Spinal instability as defined by the spinal instability neoplastic score is associated with radiotherapy failure in metastatic spinal disease. Spine J. 14, 2835\u20132840 (2014).","journal-title":"Spine J."},{"key":"1152_CR34","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1634\/theoncologist.2016-0356","volume":"22","author":"JM van der Velden","year":"2017","unstructured":"van der Velden, J. M. et al. Prospective evaluation of the relationship between mechanical stability and response to palliative radiotherapy for symptomatic spinal metastases. Oncologist 22, 972\u2013978 (2017).","journal-title":"Oncologist"},{"key":"1152_CR35","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.3171\/2025.2.FOCUS24915","volume":"58","author":"AR Bartolozzi","year":"2025","unstructured":"Bartolozzi, A. R. et al. Impact of surgery and radiation on radicular pain and myotomic weakness in patients with metastatic spine disease. Neurosurg. Focus 58, E14 (2025).","journal-title":"Neurosurg. Focus"},{"key":"1152_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","volume":"366","author":"RA Patchell","year":"2005","unstructured":"Patchell, R. A. et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366, 643\u2013648 (2005).","journal-title":"Lancet"},{"key":"1152_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.2015.61.9338","volume":"34","author":"MG Fehlings","year":"2016","unstructured":"Fehlings, M. G. et al. Survival and clinical outcomes in surgically treated patients with metastatic epidural spinal cord compression: results of the prospective Multicenter AOSpine study. J. Clin. Oncol. 34, 268\u2013276 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1152_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/neuros\/nyz472","volume":"87","author":"N Dea","year":"2020","unstructured":"Dea, N. et al. Metastatic spine disease: should patients with short life expectancy be denied surgical care? An international retrospective cohort study. Neurosurgery 87, 303\u2013311 (2020).","journal-title":"Neurosurgery"},{"key":"1152_CR39","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H. & Jemal, A. Cancer statistics, 2026. CA Cancer J. Clin. 76, e70043 (2026).","journal-title":"CA Cancer J. Clin."},{"key":"1152_CR40","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1200\/JCO.2010.34.3897","volume":"29","author":"DR Fourney","year":"2011","unstructured":"Fourney, D. R. et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J. Clin. Oncol. 29, 3072\u20133077 (2011).","journal-title":"J. Clin. Oncol."},{"key":"1152_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-9-69","volume":"9","author":"CG Fisher","year":"2014","unstructured":"Fisher, C. G. et al. Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat. Oncol. 9, 69 (2014).","journal-title":"Radiat. Oncol."},{"key":"1152_CR42","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1097\/BRS.0000000000001822","volume":"41","author":"AL Versteeg","year":"2016","unstructured":"Versteeg, A. L. et al. The spinal instability neoplastic score: impact on oncologic decision-making. Spine 41, S231\u2013S237 (2016).","journal-title":"Spine"},{"key":"1152_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13655-6","volume":"25","author":"A Pratapneni","year":"2025","unstructured":"Pratapneni, A. et al. Single- versus multi-fraction spine stereotactic radiosurgery (ALL-STAR) for patients with spinal metastases: a randomized phase III trial protocol. BMC Cancer 25, 323 (2025).","journal-title":"BMC Cancer"},{"key":"1152_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5603\/RPOR.a2023.0037","volume":"28","author":"S McClelland 3rd","year":"2023","unstructured":"McClelland, S. 3rd, Sun, Y. & Spratt, D. E. Spine patient optimal radiosurgery treatment for symptomatic metastatic neoplasms (SPORTSMEN): a randomized phase II study protocol. Rep. Pract. Oncol. Radiother. 28, 379\u2013388 (2023).","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"1152_CR45","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.spinee.2020.10.017","volume":"21","author":"AL Versteeg","year":"2021","unstructured":"Versteeg, A. L. et al. Health related quality of life outcomes following surgery and\/or radiation for patients with potentially unstable spinal metastases. Spine J. 21, 492\u2013499 (2021).","journal-title":"Spine J."},{"key":"1152_CR46","first-page":"132S","volume":"15","author":"WC Kwan","year":"2025","unstructured":"Kwan, W. C. et al. What is the optimal management of metastatic spine patients with intermediate spinal instability neoplastic scores: to operate or not to operate? Glob. Spine J. 15, 132S\u2013142S (2025).","journal-title":"Glob. Spine J."},{"key":"1152_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2025.12.029","author":"L Burgess","year":"2026","unstructured":"Burgess, L. et al. Predictors of vertebral compression fracture following stereotactic body radiation therapy in SINS potentially unstable spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.12.029 (2026).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijrobp.2019.01.072","volume":"104","author":"Z Wardak","year":"2019","unstructured":"Wardak, Z. et al. A phase 2 clinical trial of SABR followed by immediate vertebroplasty for spine metastases. Int. J. Radiat. Oncol. Biol. Phys. 104, 83\u201389 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR49","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1016\/j.wneu.2022.03.079","volume":"163","author":"S Sugita","year":"2022","unstructured":"Sugita, S., Morita, E., Fujiwara, M., Okuma, T. & Hozumi, T. Correlation between gait and life expectancy in patients with spinal metastases. World Neurosurg. 163, e156\u2013e161 (2022).","journal-title":"World Neurosurg."},{"key":"1152_CR50","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3171\/2010.3.SPINE09459","volume":"13","author":"MH Bilsky","year":"2010","unstructured":"Bilsky, M. H. et al. Reliability analysis of the epidural spinal cord compression scale. J. Neurosurg. Spine 13, 324\u2013328 (2010).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1200\/JCO.2018.78.1211","volume":"37","author":"AJ Lawton","year":"2019","unstructured":"Lawton, A. J. et al. Assessment and management of patients with metastatic spinal cord compression: a multidisciplinary review. J. Clin. Oncol. 37, 61\u201371 (2019).","journal-title":"J. Clin. Oncol."},{"key":"1152_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.14245\/ns.2142768.384","volume":"19","author":"AL Versteeg","year":"2022","unstructured":"Versteeg, A. L. et al. Steroids in the management of preoperative neurological deficits in metastatic spine disease: results from the EPOSO study. Neurospine 19, 43\u201350 (2022).","journal-title":"Neurospine"},{"key":"1152_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/082585971302900305","volume":"29","author":"I de Kock","year":"2013","unstructured":"de Kock, I. et al. Conversion of Karnofsky Performance Status (KPS) and Eastern Cooperative Oncology Group Performance Status (ECOG) to Palliative Performance Scale (PPS), and the interchangeability of PPS and KPS in prognostic tools. J. Palliat. Care 29, 163\u2013169 (2013).","journal-title":"J. Palliat. Care"},{"key":"1152_CR54","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1200\/JCO.2015.65.1497","volume":"34","author":"JJ Verlaan","year":"2016","unstructured":"Verlaan, J. J. et al. Characteristics of patients who survived >3 months or <2 years after surgery for spinal metastases: can we avoid inappropriate patient selection? J. Clin. Oncol. 34, 3054\u20133061 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1152_CR55","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/cncr.20756","volume":"103","author":"YM van der Linden","year":"2005","unstructured":"van der Linden, Y. M. et al. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103, 320\u2013328 (2005).","journal-title":"Cancer"},{"key":"1152_CR56","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/neuonc\/not318","volume":"16","author":"L Bollen","year":"2014","unstructured":"Bollen, L. et al. Prognostic factors associated with survival in patients with symptomatic spinal bone metastases: a retrospective cohort study of 1,043 patients. Neuro Oncol. 16, 991\u2013998 (2014).","journal-title":"Neuro Oncol."},{"key":"1152_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/cncr.23150","volume":"112","author":"D Rades","year":"2008","unstructured":"Rades, D., Dunst, J. & Schild, S. E. The first score predicting overall survival in patients with metastatic spinal cord compression. Cancer 112, 157\u2013161 (2008).","journal-title":"Cancer"},{"key":"1152_CR58","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/cncr.25223","volume":"116","author":"D Rades","year":"2010","unstructured":"Rades, D. et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer 116, 3670\u20133673 (2010).","journal-title":"Cancer"},{"key":"1152_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ijrobp.2015.04.050","volume":"93","author":"C Tang","year":"2015","unstructured":"Tang, C. et al. Creation of a prognostic index for spine metastasis to stratify survival in patients treated with spinal stereotactic radiosurgery: secondary analysis of mature prospective trials. Int. J. Radiat. Oncol. Biol. Phys. 93, 118\u2013125 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR60","first-page":"25","volume":"5","author":"G Jensen","year":"2017","unstructured":"Jensen, G. et al. Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery. J. Radiosurg. SBRT 5, 25\u201334 (2017).","journal-title":"J. Radiosurg. SBRT"},{"key":"1152_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110570","volume":"201","author":"MA Florez","year":"2024","unstructured":"Florez, M. A. et al. Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation. Radiother. Oncol. 201, 110570 (2024).","journal-title":"Radiother. Oncol."},{"key":"1152_CR62","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/cncr.34626","volume":"129","author":"RO Kowalchuk","year":"2023","unstructured":"Kowalchuk, R. O. et al. Development and validation of a recursive partitioning analysis-based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy. Cancer 129, 956\u2013965 (2023).","journal-title":"Cancer"},{"key":"1152_CR63","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/j.ijrobp.2023.06.356","volume":"117","author":"S Koro","year":"2023","unstructured":"Koro, S. et al. Multi-institutional validation of the recursive partitioning analysis for overall survival in patients undergoing spine radiosurgery for spine metastasis. Int. J. Radiat. Oncol. Biol. Phys. 117, S59\u2013S60 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR64","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/cncr.31870","volume":"125","author":"O Barzilai","year":"2019","unstructured":"Barzilai, O. et al. Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: a multicenter, international study. Cancer 125, 770\u2013778 (2019).","journal-title":"Cancer"},{"key":"1152_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109769","volume":"186","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. The impact of local control on widespread progression and survival in oligometastasis-directed SBRT: results from a large international database. Radiother. Oncol. 186, 109769 (2023).","journal-title":"Radiother. Oncol."},{"key":"1152_CR66","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003834","author":"AL Versteeg","year":"2025","unstructured":"Versteeg, A. L. et al. Association between nutritional status and survival in patients requiring treatment for spinal metastases. Neurosurgery https:\/\/doi.org\/10.1227\/neu.0000000000003834 (2025).","journal-title":"Neurosurgery"},{"key":"1152_CR67","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/neuros\/nyaa583","volume":"88","author":"KL Zeng","year":"2021","unstructured":"Zeng, K. L. et al. Prognostic factors associated with surviving less than 3 months vs greater than 3 years specific to spine stereotactic body radiotherapy and late adverse events. Neurosurgery 88, 971\u2013979 (2021).","journal-title":"Neurosurgery"},{"key":"1152_CR68","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s12094-021-02684-9","volume":"24","author":"H Perez-Montero","year":"2022","unstructured":"Perez-Montero, H. et al. Long-term outcomes of spinal SBRT. Is it important to select the treatment time? Clin. Transl. Oncol. 24, 276\u2013287 (2022).","journal-title":"Clin. Transl. Oncol."},{"key":"1152_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11060-025-04998-y","volume":"173","author":"B Thomsen","year":"2025","unstructured":"Thomsen, B. et al. Breast cancer spine metastases treated with stereotactic body radiation therapy: patient outcomes and predictors. J. Neurooncol. 173, 409\u2013418 (2025).","journal-title":"J. Neurooncol."},{"key":"1152_CR70","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11060-024-04603-8","volume":"167","author":"D Shor","year":"2024","unstructured":"Shor, D. et al. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy. J. Neurooncol. 167, 275\u2013283 (2024).","journal-title":"J. Neurooncol."},{"key":"1152_CR71","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/gerona\/62.7.722","volume":"62","author":"K Rockwood","year":"2007","unstructured":"Rockwood, K. & Mitnitski, A. Frailty in relation to the accumulation of deficits. J. Gerontol. A Biol. Sci. Med. Sci. 62, 722\u2013727 (2007).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"1152_CR72","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jamcollsurg.2010.01.028","volume":"210","author":"MA Makary","year":"2010","unstructured":"Makary, M. A. et al. Frailty as a predictor of surgical outcomes in older patients. J. Am. Coll. Surg. 210, 901\u2013908 (2010).","journal-title":"J. Am. Coll. Surg."},{"key":"1152_CR73","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.wneu.2016.08.029","volume":"95","author":"R De la Garza Ramos","year":"2016","unstructured":"De la Garza Ramos, R. et al. Development of a metastatic spinal tumor frailty index (MSTFI) using a nationwide database and its association with inpatient morbidity, mortality, and length of stay after spine surgery. World Neurosurg. 95, 548\u2013555.e4 (2016).","journal-title":"World Neurosurg."},{"key":"1152_CR74","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.3171\/2021.2.FOCUS201113","volume":"50","author":"E Massaad","year":"2021","unstructured":"Massaad, E. et al. Performance assessment of the metastatic spinal tumor frailty index using machine learning algorithms: limitations and future directions. Neurosurg. Focus 50, E5 (2021).","journal-title":"Neurosurg. Focus"},{"key":"1152_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.spinee.2019.08.012","volume":"20","author":"E Bourassa-Moreau","year":"2020","unstructured":"Bourassa-Moreau, E. et al. Sarcopenia, but not frailty, predicts early mortality and adverse events after emergent surgery for metastatic disease of the spine. Spine J. 20, 22\u201331 (2020).","journal-title":"Spine J."},{"key":"1152_CR76","first-page":"47S","volume":"15","author":"MA MacLean","year":"2025","unstructured":"MacLean, M. A. et al. A critical appraisal of the application of frailty and sarcopenia in the spinal oncology population. Glob. Spine J. 15, 47S\u201380S (2025).","journal-title":"Glob. Spine J."},{"key":"1152_CR77","unstructured":"Sainz, Y. C. et al. in The 12th International Conference on Bioinformatics Research and Applications (ICBRA 2025) 27\u201331 (ACM, 2025)."},{"key":"1152_CR78","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3171\/2022.1.SPINE211284","volume":"37","author":"E Massaad","year":"2022","unstructured":"Massaad, E. et al. Evaluating frailty, mortality, and complications associated with metastatic spine tumor surgery using machine learning-derived body composition analysis. J. Neurosurg. Spine 37, 263\u2013273 (2022).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR79","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ijrobp.2024.11.082","volume":"121","author":"AW Chan","year":"2025","unstructured":"Chan, A. W. et al. Spine stereotactic body radiation therapy in geriatric patients: implications of age and dose on iatrogenic vertebral compression fracture risk. Int. J. Radiat. Oncol. Biol. Phys. 121, 1185\u20131193 (2025).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR80","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.radonc.2018.04.030","volume":"128","author":"T Sprave","year":"2018","unstructured":"Sprave, T. et al. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy. Radiother. Oncol. 128, 274\u2013282 (2018).","journal-title":"Radiother. Oncol."},{"key":"1152_CR81","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06391242 (2026)."},{"key":"1152_CR82","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijrobp.2019.02.046","volume":"110","author":"AE Marciscano","year":"2021","unstructured":"Marciscano, A. E. et al. Immunomodulatory effects of stereotactic body radiation therapy: preclinical insights and clinical opportunities. Int. J. Radiat. Oncol. Biol. Phys. 110, 35\u201352 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR83","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ijrobp.2013.07.022","volume":"88","author":"JM Brown","year":"2014","unstructured":"Brown, J. M., Carlson, D. J. & Brenner, D. J. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int. J. Radiat. Oncol. Biol. Phys. 88, 254\u2013262 (2014).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR84","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1667\/RR2773.1","volume":"177","author":"HJ Park","year":"2012","unstructured":"Park, H. J., Griffin, R. J., Hui, S., Levitt, S. H. & Song, C. W. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat. Res. 177, 311\u2013327 (2012).","journal-title":"Radiat. Res."},{"key":"1152_CR85","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1172\/JCI97631","volume":"129","author":"S Bodo","year":"2019","unstructured":"Bodo, S. et al. Single-dose radiotherapy disables tumor cell homologous recombination via ischemia\/reperfusion injury. J. Clin. Invest. 129, 786\u2013801 (2019).","journal-title":"J. Clin. Invest."},{"key":"1152_CR86","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.ijrobp.2018.01.005","volume":"100","author":"JG Steverink","year":"2018","unstructured":"Steverink, J. G. et al. Early tissue effects of stereotactic body radiation therapy for spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 100, 1254\u20131258 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR87","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-020-03691-6","volume":"152","author":"KL Zeng","year":"2021","unstructured":"Zeng, K. L. et al. Local control and patterns of failure for \u201cradioresistant\u201d spinal metastases following stereotactic body radiotherapy compared to a \u201cradiosensitive\u201d reference. J. Neurooncol. 152, 173\u2013182 (2021).","journal-title":"J. Neurooncol."},{"key":"1152_CR88","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ijrobp.2017.08.028","volume":"99","author":"V Bernard","year":"2017","unstructured":"Bernard, V. et al. Heterogeneity in treatment response of spine metastases to spine stereotactic radiosurgery within \u201cradiosensitive\u201d subtypes. Int. J. Radiat. Oncol. Biol. Phys. 99, 1207\u20131215 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR89","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/jjco\/hyaa128","volume":"50","author":"K Ito","year":"2020","unstructured":"Ito, K., Yamaguchi, T., Ogawa, H., Nakajima, Y. & Karasawa, K. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer. Jpn. J. Clin. Oncol. 50, 1442\u20131446 (2020).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"1152_CR90","volume":"3","author":"D Sit","year":"2022","unstructured":"Sit, D., Bale, M., Lapointe, V., Olson, R. & Hsu, F. Association between EGFR and ALK mutation status on patient-reported symptoms after palliative radiation for bone pain in NSCLC. JTO Clin. Res. Rep. 3, 100371 (2022).","journal-title":"JTO Clin. Res. Rep."},{"key":"1152_CR91","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.prro.2021.12.012","volume":"12","author":"RO Kowalchuk","year":"2022","unstructured":"Kowalchuk, R. O. et al. Cost-effectiveness of treatment strategies for spinal metastases. Pract. Radiat. Oncol. 12, 236\u2013244 (2022).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.110906","volume":"207","author":"AM Nielsen","year":"2025","unstructured":"Nielsen, A. M. et al. Esophagus-sparing radiotherapy for complicated spinal metastases (ESO-SPARE). A randomized phase III clinical trial. Radiother. Oncol. 207, 110906 (2025).","journal-title":"Radiother. Oncol."},{"key":"1152_CR93","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.clon.2015.01.035","volume":"27","author":"AK Anand","year":"2015","unstructured":"Anand, A. K. et al. Hypofractionated stereotactic body radiotherapy in spinal metastasis \u2014 with or without epidural extension. Clin. Oncol. 27, 345\u2013352 (2015).","journal-title":"Clin. Oncol."},{"key":"1152_CR94","volume":"8","author":"RS Pathak","year":"2022","unstructured":"Pathak, R. S. et al. Practice patterns and perspectives on stereotactic body radiation therapy for the metastatic spine from lower-income and middle-income countries. JCO Glob. Oncol. 8, e220016 (2022).","journal-title":"JCO Glob. Oncol."},{"key":"1152_CR95","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ijrobp.2011.12.039","volume":"84","author":"W Li","year":"2012","unstructured":"Li, W. et al. Impact of immobilization on intrafraction motion for spine stereotactic body radiotherapy using cone beam computed tomography. Int. J. Radiat. Oncol. Biol. Phys. 84, 520\u2013526 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR96","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/j.ijrobp.2009.04.027","volume":"75","author":"L Ma","year":"2009","unstructured":"Ma, L. et al. Nonrandom intrafraction target motions and general strategy for correction of spine stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 75, 1261\u20131265 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR97","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3171\/spi.2005.2.5.0540","volume":"2","author":"JW Degen","year":"2005","unstructured":"Degen, J. W. et al. CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life. J. Neurosurg. Spine 2, 540\u2013549 (2005).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR98","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.ijrobp.2016.01.006","volume":"94","author":"C Hazelaar","year":"2016","unstructured":"Hazelaar, C. et al. Subsecond and submillimeter resolution positional verification for stereotactic irradiation of spinal lesions. Int. J. Radiat. Oncol. Biol. Phys. 94, 1154\u20131162 (2016).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR99","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211063033","volume":"20","author":"J Koo","year":"2021","unstructured":"Koo, J. et al. Triggered kV imaging during spine sbrt for intrafraction motion management. Technol. Cancer Res. Treat. 20, 15330338211063033 (2021).","journal-title":"Technol. Cancer Res. Treat."},{"key":"1152_CR100","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11060-024-04755-7","volume":"169","author":"H Shimizu","year":"2024","unstructured":"Shimizu, H. et al. Frequency of and risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery. J. Neurooncol. 169, 563\u2013570 (2024).","journal-title":"J. Neurooncol."},{"key":"1152_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-022-02058-7","volume":"17","author":"D Henzen","year":"2022","unstructured":"Henzen, D. et al. Feasibility of postoperative spine stereotactic body radiation therapy in proximity of carbon and titanium hybrid implants using a robotic radiotherapy device. Radiat. Oncol. 17, 94 (2022).","journal-title":"Radiat. Oncol."},{"key":"1152_CR102","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/sc.2015.43","volume":"53","author":"CS Wong","year":"2015","unstructured":"Wong, C. S., Fehlings, M. G. & Sahgal, A. Pathobiology of radiation myelopathy and strategies to mitigate injury. Spinal Cord 53, 574\u2013580 (2015).","journal-title":"Spinal Cord"},{"key":"1152_CR103","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ijrobp.2014.12.037","volume":"91","author":"CL Tseng","year":"2015","unstructured":"Tseng, C. L. et al. Magnetic resonance imaging assessment of spinal cord and cauda equina motion in supine patients with spinal metastases planned for spine stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 91, 995\u20131002 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR104","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijrobp.2019.09.038","volume":"110","author":"A Sahgal","year":"2021","unstructured":"Sahgal, A. et al. Spinal cord dose tolerance to stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 110, 124\u2013136 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR105","doi-asserted-by":"publisher","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","volume":"16","author":"I Thibault","year":"2015","unstructured":"Thibault, I. et al. Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group. Lancet Oncol. 16, e595\u2013e603 (2015).","journal-title":"Lancet Oncol."},{"key":"1152_CR106","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.ijrobp.2021.08.023","volume":"112","author":"EM Dunne","year":"2022","unstructured":"Dunne, E. M. et al. Thecal sac contouring as a surrogate for the cauda equina and intracanal spinal nerve roots for spine stereotactic body radiation therapy (SBRT): contour variability and recommendations for safe practice. Int. J. Radiat. Oncol. Biol. Phys. 112, 114\u2013120 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR107","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","volume":"83","author":"BW Cox","year":"2012","unstructured":"Cox, B. W. et al. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int. J. Radiat. Oncol. Biol. Phys. 83, e597\u2013e605 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR108","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijrobp.2016.09.014","volume":"97","author":"KJ Redmond","year":"2017","unstructured":"Redmond, K. J. et al. Consensus contouring guidelines for postoperative stereotactic body radiation therapy for metastatic solid tumor malignancies to the spine. Int. J. Radiat. Oncol. Biol. Phys. 97, 64\u201374 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR109","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2019.11.026","volume":"145","author":"EM Dunne","year":"2020","unstructured":"Dunne, E. M. et al. International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT). Radiother. Oncol. 145, 21\u201329 (2020).","journal-title":"Radiother. Oncol."},{"key":"1152_CR110","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.prro.2023.03.009","volume":"13","author":"L Burgess","year":"2023","unstructured":"Burgess, L. et al. Stereotactic body radiation therapy for posterior element-only spinal metastases: a first report on outcomes and validation of recommended clinical target volume delineation practice. Pract. Radiat. Oncol. 13, 321\u2013327 (2023).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR111","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/neuonc\/noaf254","volume":"28","author":"YL Chen","year":"2025","unstructured":"Chen, Y. L. et al. Elective versus involved target volume definition of stereotactic spine radiosurgery for spinal metastases: a phase 2 randomized clinical trial. Neuro Oncol. 28, 495\u2013504 (2025).","journal-title":"Neuro Oncol."},{"key":"1152_CR112","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ijrobp.2024.01.213","volume":"119","author":"D Moore-Palhares","year":"2024","unstructured":"Moore-Palhares, D. et al. Stereotactic body radiation therapy for sacral metastases: deviation from recommended target volume delineation increases the risk of local failure. Int. J. Radiat. Oncol. Biol. Phys. 119, 1110\u20131121 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR113","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijrobp.2020.11.021","volume":"110","author":"SG Soltys","year":"2021","unstructured":"Soltys, S. G. et al. Stereotactic body radiation therapy for spinal metastases: tumor control probability analyses and recommended reporting standards. Int. J. Radiat. Oncol. Biol. Phys. 110, 112\u2013123 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR114","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamaoncol.2023.0356","volume":"9","author":"S Ryu","year":"2023","unstructured":"Ryu, S. et al. Stereotactic radiosurgery vs conventional radiotherapy for localized vertebral metastases of the spine: phase 3 results of NRG Oncology\/RTOG 0631 randomized clinical trial. JAMA Oncol. 9, 800\u2013807 (2023).","journal-title":"JAMA Oncol."},{"key":"1152_CR115","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/neuros\/nyx493","volume":"83","author":"S Faruqi","year":"2018","unstructured":"Faruqi, S. et al. Vertebral compression fracture after spine stereotactic body radiation therapy: a review of the pathophysiology and risk factors. Neurosurgery 83, 314\u2013322 (2018).","journal-title":"Neurosurgery"},{"key":"1152_CR116","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ijrobp.2025.05.078","volume":"123","author":"CB Jackson","year":"2025","unstructured":"Jackson, C. B. et al. Histologic classifier of radiosensitivity to spine stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 123, 829\u2013838 (2025).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110119","volume":"193","author":"MD Shanker","year":"2024","unstructured":"Shanker, M. D. et al. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk. Radiother. Oncol. 193, 110119 (2024).","journal-title":"Radiother. Oncol."},{"key":"1152_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2025.103961","volume":"49","author":"C Udovicich","year":"2025","unstructured":"Udovicich, C. et al. Boosting the evidence: time to integrate simultaneous integrated boost in spine stereotactic body radiotherapy? Clin. Oncol. 49, 103961 (2025).","journal-title":"Clin. Oncol."},{"key":"1152_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.110940","volume":"208","author":"M Guckenberger","year":"2025","unstructured":"Guckenberger, M. et al. Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial. Radiother. Oncol. 208, 110940 (2025).","journal-title":"Radiother. Oncol."},{"key":"1152_CR120","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.meddos.2020.02.005","volume":"45","author":"N Hardcastle","year":"2020","unstructured":"Hardcastle, N. et al. The challenge of planning vertebral body SBRT: optimizing target volume coverage. Med. Dosim. 45, 302\u2013307 (2020).","journal-title":"Med. Dosim."},{"key":"1152_CR121","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/PPO.0000000000000205","volume":"22","author":"S Jabbari","year":"2016","unstructured":"Jabbari, S. et al. Stereotactic body radiotherapy for spinal metastases: practice guidelines, outcomes, and risks. Cancer J. 22, 280\u2013289 (2016).","journal-title":"Cancer J."},{"key":"1152_CR122","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0167-8140(02)00170-6","volume":"64","author":"E Chow","year":"2002","unstructured":"Chow, E. et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother. Oncol. 64, 275\u2013280 (2002).","journal-title":"Radiother. Oncol."},{"key":"1152_CR123","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ijrobp.2017.07.029","volume":"99","author":"JM van der Velden","year":"2017","unstructured":"van der Velden, J. M. et al. Development and internal validation of a clinical risk score to predict pain response after palliative radiation therapy in patients with bone metastases. Int. J. Radiat. Oncol. Biol. Phys. 99, 859\u2013866 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR124","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.ijrobp.2020.11.060","volume":"110","author":"BJ Pielkenrood","year":"2021","unstructured":"Pielkenrood, B. J. et al. Pain response after stereotactic body radiation therapy versus conventional radiation therapy in patients with bone metastases \u2014 a phase 2 randomized controlled trial within a prospective cohort. Int. J. Radiat. Oncol. Biol. Phys. 110, 358\u2013367 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR125","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1200\/JCO-24-01447","volume":"43","author":"C Mercier","year":"2025","unstructured":"Mercier, C. et al. Dose-escalated stereotactic versus conventional radiotherapy for painful bone metastases (ROBOMET): a multicenter, patient-blinded randomized clinical trial. J. Clin. Oncol.\u00a043, 2164\u20132172\u00a0(2025).","journal-title":"J. Clin. Oncol."},{"key":"1152_CR126","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ijrobp.2022.10.017","volume":"115","author":"X Song","year":"2023","unstructured":"Song, X. et al. Stereotactic body radiation therapy versus conventional radiation therapy in pain relief for bone metastases: a systematic review and meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 115, 909\u2013921 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR127","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.55409","volume":"7","author":"BJJ Bindels","year":"2024","unstructured":"Bindels, B. J. J. et al. Stereotactic body and conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis. JAMA Netw. Open 7, e2355409 (2024).","journal-title":"JAMA Netw. Open"},{"key":"1152_CR128","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1227\/neu.0000000000001909","volume":"90","author":"A Abugharib","year":"2022","unstructured":"Abugharib, A. et al. Spine stereotactic body radiotherapy for prostate cancer metastases and the impact of hormone sensitivity status on local control. Neurosurgery 90, 743\u2013749 (2022).","journal-title":"Neurosurgery"},{"key":"1152_CR129","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ijrobp.2022.09.076","volume":"115","author":"KL Zeng","year":"2023","unstructured":"Zeng, K. L. et al. Dose-escalated 2-fraction spine stereotactic body radiation therapy: 28 Gy versus 24 Gy in 2 daily fractions. Int. J. Radiat. Oncol. Biol. Phys. 115, 686\u2013695 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR130","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.ijrobp.2024.02.010","volume":"119","author":"H Chen","year":"2024","unstructured":"Chen, H. et al. Magnetic resonance imaging frequency after stereotactic body radiation therapy for spine metastases. Int. J. Radiat. Oncol. Biol. Phys. 119, 1413\u20131421 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR131","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1093\/neuros\/nyy176","volume":"84","author":"R Jakubovic","year":"2019","unstructured":"Jakubovic, R. et al. Surgical resection with radiation treatment planning of spinal tumors. Neurosurgery 84, 1242\u20131250 (2019).","journal-title":"Neurosurgery"},{"key":"1152_CR132","doi-asserted-by":"publisher","first-page":"E1111","DOI":"10.1093\/neuros\/nyz349","volume":"85","author":"M Alghamdi","year":"2019","unstructured":"Alghamdi, M. et al. Postoperative stereotactic body radiotherapy for spinal metastases and the impact of epidural disease grade. Neurosurgery 85, E1111\u2013E1118 (2019).","journal-title":"Neurosurgery"},{"key":"1152_CR133","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/neuonc\/not101","volume":"15","author":"A Al-Omair","year":"2013","unstructured":"Al-Omair, A. et al. Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy. Neuro Oncol. 15, 1413\u20131419 (2013).","journal-title":"Neuro Oncol."},{"key":"1152_CR134","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/j.ijrobp.2024.07.652","volume":"120","author":"S Zayed","year":"2024","unstructured":"Zayed, S. et al. Prognostic factors for local failure and overall survival in patients with epidural disease at the cauda equina following stereotactic body radiotherapy: a clinical, anatomic and dosimetric analysis. Int. J. Radiat. Oncol. Biol. Phys. 120, e293\u2013e294 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR135","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ijrobp.2012.05.007","volume":"85","author":"A Sahgal","year":"2013","unstructured":"Sahgal, A. et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int. J. Radiat. Oncol. Biol. Phys. 85, 341\u2013347 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR136","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/jamaoncol.2024.5387","volume":"11","author":"CB Jackson","year":"2025","unstructured":"Jackson, C. B. et al. Radiation myelitis risk after hypofractionated spine stereotactic body radiation therapy. JAMA Oncol. 11, 128\u2013134 (2025).","journal-title":"JAMA Oncol."},{"key":"1152_CR137","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ijrobp.2009.10.056","volume":"79","author":"M Mizumoto","year":"2011","unstructured":"Mizumoto, M. et al. Radiotherapy for patients with metastases to the spinal column: a review of 603 patients at Shizuoka Cancer Center Hospital. Int. J. Radiat. Oncol. Biol. Phys. 79, 208\u2013213 (2011).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR138","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3171\/2025.6.SPINE25376","volume":"44","author":"WL Ong","year":"2025","unstructured":"Ong, W. L. et al. Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter? J. Neurosurg. Spine 44, 284\u2013292 (2025).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR139","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijrobp.2011.10.080","volume":"84","author":"M Huisman","year":"2012","unstructured":"Huisman, M. et al. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int. J. Radiat. Oncol. Biol. Phys. 84, 8\u201314 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR140","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1470-2045(13)70556-4","volume":"15","author":"E Chow","year":"2014","unstructured":"Chow, E. et al. Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol. 15, 164\u2013171 (2014).","journal-title":"Lancet Oncol."},{"key":"1152_CR141","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1227\/00006123-199502000-00010","volume":"36","author":"AJ Hamilton","year":"1995","unstructured":"Hamilton, A. J., Lulu, B. A., Fosmire, H., Stea, B. & Cassady, J. R. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurgery 36, 311\u2013319 (1995).","journal-title":"Neurosurgery"},{"key":"1152_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.111304","volume":"214","author":"F Alongi","year":"2026","unstructured":"Alongi, F. et al. ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal mestastases with Stereotactic body radiotherapy: Delphi consensus supported by a systematic review and meta-analysis. Radiother. Oncol. 214, 111304 (2026).","journal-title":"Radiother. Oncol."},{"key":"1152_CR143","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/jjco\/hyaf215","volume":"56","author":"K Ito","year":"2026","unstructured":"Ito, K. et al. Phase II trial of re-irradiation stereotactic body radiotherapy for painful spinal metastases. Jpn. J. Clin. Oncol. 56, 428\u2013434 (2026).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"1152_CR144","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.ijrobp.2015.03.029","volume":"93","author":"I Thibault","year":"2015","unstructured":"Thibault, I. et al. Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial sbrt for spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 93, 353\u2013360 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR145","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/jjco\/hyac070","volume":"52","author":"K Ito","year":"2022","unstructured":"Ito, K., Nakajima, Y., Ogawa, H., Taguchi, K. & Sugita, S. Risk of radiculopathy caused by second course of spine stereotactic body radiotherapy. Jpn. J. Clin. Oncol. 52, 911\u2013916 (2022).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"1152_CR146","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1227\/neu.0000000000002889","volume":"95","author":"A Moore","year":"2024","unstructured":"Moore, A. et al. 40 Gray in 5 fractions for salvage reirradiation of spine lesions previously treated with stereotactic body radiotherapy. Neurosurgery 95, 380\u2013391 (2024).","journal-title":"Neurosurgery"},{"key":"1152_CR147","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jbo.2014.10.001","volume":"3","author":"R McDonald","year":"2014","unstructured":"McDonald, R., Chow, E., Rowbottom, L., DeAngelis, C. & Soliman, H. Incidence of pain flare in radiation treatment of bone metastases: a literature review. J. Bone Oncol. 3, 84\u201389 (2014).","journal-title":"J. Bone Oncol."},{"key":"1152_CR148","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijrobp.2013.03.022","volume":"86","author":"A Chiang","year":"2013","unstructured":"Chiang, A. et al. Pain flare is a common adverse event in steroid-naive patients after spine stereotactic body radiation therapy: a prospective clinical trial. Int. J. Radiat. Oncol. Biol. Phys. 86, 638\u2013642 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR149","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1016\/j.prro.2022.01.011","volume":"12","author":"RO Kowalchuk","year":"2022","unstructured":"Kowalchuk, R. O. et al. Development and internal validation of a recursive partitioning analysis-based model predictive of pain flare incidence after spine stereotactic body radiation therapy. Pract. Radiat. Oncol. 12, e269\u2013e277 (2022).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR150","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/S1470-2045(15)00199-0","volume":"16","author":"E Chow","year":"2015","unstructured":"Chow, E. et al. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. Lancet Oncol. 16, 1463\u20131472 (2015).","journal-title":"Lancet Oncol."},{"key":"1152_CR151","first-page":"2937","volume":"23","author":"L Khan","year":"2015","unstructured":"Khan, L. et al. Prophylactic dexamethasone effectively reduces the incidence of pain flare following spine stereotactic body radiotherapy (SBRT): a prospective observational study. Support. Care Cancer 23, 2937\u20132943 (2015).","journal-title":"Support. Care Cancer"},{"key":"1152_CR152","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1016\/S1470-2045(13)70101-3","volume":"14","author":"A Sahgal","year":"2013","unstructured":"Sahgal, A., Whyne, C. M., Ma, L., Larson, D. A. & Fehlings, M. G. Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases. Lancet Oncol. 14, e310\u2013e320 (2013).","journal-title":"Lancet Oncol."},{"key":"1152_CR153","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3171\/2011.11.SPINE116","volume":"16","author":"NS Boehling","year":"2012","unstructured":"Boehling, N. S. et al. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases. J. Neurosurg. Spine 16, 379\u2013386 (2012).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR154","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y","volume":"88","author":"TA Guise","year":"2000","unstructured":"Guise, T. A. Molecular mechanisms of osteolytic bone metastases. Cancer 88, 2892\u20132898 (2000).","journal-title":"Cancer"},{"key":"1152_CR155","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1200\/JCO.2008.19.3508","volume":"27","author":"PS Rose","year":"2009","unstructured":"Rose, P. S. et al. Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. J. Clin. Oncol. 27, 5075\u20135079 (2009).","journal-title":"J. Clin. Oncol."},{"key":"1152_CR156","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3171\/2013.2.SPINE12739","volume":"18","author":"A Al-Omair","year":"2013","unstructured":"Al-Omair, A. et al. Radiation-induced vertebral compression fracture following spine stereotactic radiosurgery: clinicopathological correlation. J. Neurosurg. Spine 18, 430\u2013435 (2013).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR157","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","volume":"31","author":"A Sahgal","year":"2013","unstructured":"Sahgal, A. et al. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J. Clin. Oncol. 31, 3426\u20133431 (2013).","journal-title":"J. Clin. Oncol."},{"key":"1152_CR158","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jamaoncol.2021.7008","volume":"8","author":"RO Kowalchuk","year":"2022","unstructured":"Kowalchuk, R. O. et al. Development and assessment of a predictive score for vertebral compression fracture after stereotactic body radiation therapy for spinal metastases. JAMA Oncol. 8, 412\u2013419 (2022).","journal-title":"JAMA Oncol."},{"key":"1152_CR159","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1016\/j.ijrobp.2012.04.034","volume":"84","author":"MV Cunha","year":"2012","unstructured":"Cunha, M. V. et al. Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors. Int. J. Radiat. Oncol. Biol. Phys. 84, e343\u2013e349 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR160","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.radonc.2019.08.026","volume":"141","author":"F Mantel","year":"2019","unstructured":"Mantel, F. et al. Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: long-term results of a prospective phase 2 study. Radiother. Oncol. 141, 62\u201366 (2019).","journal-title":"Radiother. Oncol."},{"key":"1152_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2025.110912","volume":"208","author":"L Burgess","year":"2025","unstructured":"Burgess, L. et al. A machine learning tool for prediction of vertebral compression fracture following stereotactic body radiation therapy for spinal metastases. Radiother. Oncol. 208, 110912 (2025).","journal-title":"Radiother. Oncol."},{"key":"1152_CR162","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1227\/neu.0000000000002498","volume":"93","author":"D Moore-Palhares","year":"2023","unstructured":"Moore-Palhares, D. et al. 30 Gy in 4 stereotactic body radiotherapy fractions for complex spinal metastases: mature outcomes supporting this novel regimen. Neurosurgery 93, 813\u2013823 (2023).","journal-title":"Neurosurgery"},{"key":"1152_CR163","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","volume":"102","author":"CL Tseng","year":"2018","unstructured":"Tseng, C. L. et al. Imaging-based outcomes for 24 Gy in 2 daily fractions for patients with de novo spinal metastases treated with spine stereotactic body radiation therapy (SBRT). Int. J. Radiat. Oncol. Biol. Phys. 102, 499\u2013507 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR164","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2016.09.029","volume":"97","author":"I Thibault","year":"2017","unstructured":"Thibault, I. et al. Volume of lytic vertebral body metastatic disease quantified using computed tomography-based image segmentation predicts fracture risk after spine stereotactic body radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 97, 75\u201381 (2017).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR165","unstructured":"Gulta, D. K. G. et al. in 2025 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB) 1\u20138 (IEEE, 2025)."},{"key":"1152_CR166","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10585-020-10049-9","volume":"37","author":"M Hardisty","year":"2020","unstructured":"Hardisty, M. et al. CT based quantitative measures of the stability of fractured metastatically involved vertebrae treated with spine stereotactic body radiotherapy. Clin. Exp. Metastasis 37, 575\u2013584 (2020).","journal-title":"Clin. Exp. Metastasis"},{"key":"1152_CR167","unstructured":"Klein, G. C. I. et al. in Proceedings of the 10th International Society of Orthopaedic Centers (ISOC) Conference (ISOC, 2022)."},{"key":"1152_CR168","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1118\/1.2746498","volume":"34","author":"M Hardisty","year":"2007","unstructured":"Hardisty, M., Gordon, L., Agarwal, P., Skrinskas, T. & Whyne, C. Quantitative characterization of metastatic disease in the spine. Part I. Semiautomated segmentation using atlas-based deformable registration and the level set method. Med. Phys. 34, 3127\u20133134 (2007).","journal-title":"Med. Phys."},{"key":"1152_CR169","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1118\/1.2756939","volume":"34","author":"C Whyne","year":"2007","unstructured":"Whyne, C. et al. Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analyses. Med. Phys. 34, 3279\u20133285 (2007).","journal-title":"Med. Phys."},{"key":"1152_CR170","doi-asserted-by":"publisher","unstructured":"Klein, G., Hardisty, M., Whyne, C. & Martel, A. L. VertDetect: fully end-to-end 3d vertebral instance segmentation model. Preprint at https:\/\/doi.org\/10.48550\/arXiv.2311.09958 (2023).","DOI":"10.48550\/arXiv.2311.09958"},{"key":"1152_CR171","doi-asserted-by":"crossref","unstructured":"Klein, G., Martel, A. L., Sahgal, A., Whyne, C. & Hardisty, M. in Computational Methods and Clinical Applications for Spine Imaging (eds Cai, Y. et al.) 15\u201328 (Springer, 2020) [Series Lecture Notes in Computer Science Vol. 11963].","DOI":"10.1007\/978-3-030-39752-4_2"},{"key":"1152_CR172","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S1470-2045(11)70008-0","volume":"12","author":"J Berenson","year":"2011","unstructured":"Berenson, J. et al. Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial. Lancet Oncol. 12, 225\u2013235 (2011).","journal-title":"Lancet Oncol."},{"key":"1152_CR173","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/neuonc\/noaf231","volume":"28","author":"R Kotecha","year":"2025","unstructured":"Kotecha, R. et al. Radiation therapy (RT) alone versus RT plus radiofrequency ablation\/vertebral augmentation for painful spine metastasis: a phase 2 randomized controlled trial. Neuro Oncol. 28, 241\u2013250 (2025).","journal-title":"Neuro Oncol."},{"key":"1152_CR174","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.spinee.2015.03.037","volume":"15","author":"N Moussazadeh","year":"2015","unstructured":"Moussazadeh, N. et al. Short-segment percutaneous pedicle screw fixation with cement augmentation for tumor-induced spinal instability. Spine J. 15, 1609\u20131617 (2015).","journal-title":"Spine J."},{"key":"1152_CR175","doi-asserted-by":"publisher","first-page":"e889","DOI":"10.1016\/j.wneu.2018.08.182","volume":"120","author":"O Barzilai","year":"2018","unstructured":"Barzilai, O. et al. Minimal access surgery for spinal metastases: prospective evaluation of a treatment algorithm using patient-reported outcomes. World Neurosurg. 120, e889\u2013e901 (2018).","journal-title":"World Neurosurg."},{"key":"1152_CR176","doi-asserted-by":"publisher","first-page":"S238","DOI":"10.1097\/BRS.0000000000001823","volume":"41","author":"JH Chang","year":"2016","unstructured":"Chang, J. H. et al. Stereotactic body radiotherapy for spinal metastases: what are the risks and how do we minimize them? Spine 41, S238\u2013S245 (2016).","journal-title":"Spine"},{"key":"1152_CR177","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1007\/s00586-004-0839-5","volume":"14","author":"R Schmidt","year":"2005","unstructured":"Schmidt, R. et al. Cement leakage during vertebroplasty: an underestimated problem? Eur. Spine J. 14, 466\u2013473 (2005).","journal-title":"Eur. Spine J."},{"key":"1152_CR178","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3171\/2014.4.SPINE13695","volume":"21","author":"JP Cruz","year":"2014","unstructured":"Cruz, J. P., Sahgal, A., Whyne, C., Fehlings, M. G. & Smith, R. Tumor extravasation following a cement augmentation procedure for vertebral compression fracture in metastatic spinal disease. J. Neurosurg. Spine 21, 372\u2013377 (2014).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR179","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijrobp.2010.08.021","volume":"82","author":"A Sahgal","year":"2012","unstructured":"Sahgal, A. et al. Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 82, 107\u2013116 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR180","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3109\/0284186X.2012.666637","volume":"51","author":"UK Chang","year":"2012","unstructured":"Chang, U. K. et al. Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group. Acta. Oncol. 51, 589\u2013595 (2012).","journal-title":"Acta. Oncol."},{"key":"1152_CR181","volume":"6","author":"AJ Ghia","year":"2021","unstructured":"Ghia, A. J. et al. Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously irradiated metastatic epidural spinal cord compression. N. Am. Spine Soc. J. 6, 100066 (2021).","journal-title":"N. Am. Spine Soc. J."},{"key":"1152_CR182","volume":"15","author":"LR Almeida","year":"2023","unstructured":"Almeida, L. R. et al. Radiation-induced lumbosacral plexopathy. Cureus 15, e36842 (2023).","journal-title":"Cureus"},{"key":"1152_CR183","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.ijrobp.2019.11.417","volume":"106","author":"B Hrycushko","year":"2020","unstructured":"Hrycushko, B. et al. Existence of a dose-length effect in spinal nerves receiving single-session stereotactic ablative radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 106, 1010\u20131016 (2020).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR184","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2025.100840","volume":"36","author":"K Daneshvar","year":"2025","unstructured":"Daneshvar, K. et al. Radiological response assessment after stereotactic body radiotherapy for spine metastases using magnetic resonance imaging: a systematic review. Phys. Imaging Radiat. Oncol. 36, 100840 (2025).","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"1152_CR185","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/neuros\/nyy075","volume":"84","author":"P Jabehdar Maralani","year":"2019","unstructured":"Jabehdar Maralani, P. et al. Incidence and time of onset of osseous pseudoprogression in patients with metastatic spine disease from renal cell or prostate carcinoma after treatment with stereotactic body radiation therapy. Neurosurgery 84, 647\u2013654 (2019).","journal-title":"Neurosurgery"},{"key":"1152_CR186","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s11060-022-04152-y","volume":"160","author":"P Jabehdar Maralani","year":"2022","unstructured":"Jabehdar Maralani, P. et al. Proposing a quantitative MRI-based linear measurement framework for response assessment following stereotactic body radiation therapy in patients with spinal metastasis. J. Neurooncol 160, 265\u2013272 (2022).","journal-title":"J. Neurooncol"},{"key":"1152_CR187","doi-asserted-by":"publisher","first-page":"698127","DOI":"10.1155\/2014\/698127","volume":"2014","author":"S Cappabianca","year":"2014","unstructured":"Cappabianca, S. et al. Assessing response to radiation therapy treatment of bone metastases: short-term followup of radiation therapy treatment of bone metastases with diffusion-weighted magnetic resonance imaging. J. Radiother. 2014, 698127 (2014).","journal-title":"J. Radiother."},{"key":"1152_CR188","first-page":"906","volume":"23","author":"WM Byun","year":"2002","unstructured":"Byun, W. M. et al. Diffusion-weighted MR imaging of metastatic disease of the spine: assessment of response to therapy. AJNR Am. J. Neuroradiol. 23, 906\u2013912 (2002).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1152_CR189","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.spinee.2015.08.041","volume":"16","author":"DE Spratt","year":"2016","unstructured":"Spratt, D. E. et al. Early magnetic resonance imaging biomarkers to predict local control after high dose stereotactic body radiotherapy for patients with sarcoma spine metastases. Spine J. 16, 291\u2013298 (2016).","journal-title":"Spine J."},{"key":"1152_CR190","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijrobp.2023.12.052","volume":"119","author":"M Kerba","year":"2024","unstructured":"Kerba, M. et al. An economic analysis of SC24 in Canada: a randomized study of sbrt compared with conventional palliative RT for spinal metastases. Int. J. Radiat. Oncol. Biol. Phys. 119, 1061\u20131068 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR191","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3171\/2014.7.SPINE131007","volume":"21","author":"N Dea","year":"2014","unstructured":"Dea, N. et al. Adverse events in emergency oncological spine surgery: a prospective analysis. J. Neurosurg. Spine 21, 698\u2013703 (2014).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR192","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3171\/2014.10.SPINE131201","volume":"22","author":"M Miscusi","year":"2015","unstructured":"Miscusi, M. et al. Comparison of minimally invasive surgery with standard open surgery for vertebral thoracic metastases causing acute myelopathy in patients with short- or mid-term life expectancy: surgical technique and early clinical results. J. Neurosurg. Spine 22, 518\u2013525 (2015).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR193","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/BRS.0000000000001893","volume":"42","author":"N Hansen-Algenstaedt","year":"2017","unstructured":"Hansen-Algenstaedt, N. et al. Comparison between minimally invasive surgery and conventional open surgery for patients with spinal metastasis: a prospective propensity score-matched study. Spine 42, 789\u2013797 (2017).","journal-title":"Spine"},{"key":"1152_CR194","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7785\/tcrt.2012.500230","volume":"11","author":"E Massicotte","year":"2012","unstructured":"Massicotte, E., Foote, M., Reddy, R. & Sahgal, A. Minimal access spine surgery (MASS) for decompression and stabilization performed as an out-patient procedure for metastatic spinal tumours followed by spine stereotactic body radiotherapy (SBRT): first report of technique and preliminary outcomes. Technol. Cancer Res. Treat. 11, 15\u201325 (2012).","journal-title":"Technol. Cancer Res. Treat."},{"key":"1152_CR195","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.1097\/BRS.0000000000001824","volume":"41","author":"SL Zuckerman","year":"2016","unstructured":"Zuckerman, S. L. et al. When less is more: the indications for MIS techniques and separation surgery in metastatic spine disease. Spine 41, S246\u2013S253 (2016).","journal-title":"Spine"},{"key":"1152_CR196","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3171\/2012.11.SPINE12111","volume":"18","author":"I Laufer","year":"2013","unstructured":"Laufer, I. et al. Local disease control for spinal metastases following \u201cseparation surgery\u201d and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. J. Neurosurg. Spine 18, 207\u2013214 (2013).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR197","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3171\/2010.3.SPINE09639","volume":"13","author":"HD Moulding","year":"2010","unstructured":"Moulding, H. D. et al. Local disease control after decompressive surgery and adjuvant high-dose single-fraction radiosurgery for spine metastases. J. Neurosurg. Spine 13, 87\u201393 (2010).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR198","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijrobp.2021.07.1690","volume":"112","author":"K Ito","year":"2022","unstructured":"Ito, K. et al. Phase 2 clinical trial of separation surgery followed by stereotactic body radiation therapy for metastatic epidural spinal cord compression. Int. J. Radiat. Oncol. Biol. Phys. 112, 106\u2013113 (2022).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR199","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.phro.2020.09.005","volume":"16","author":"T Furuya","year":"2020","unstructured":"Furuya, T. et al. Evaluation of multi-institutional end-to-end testing for post-operative spine stereotactic body radiation therapy. Phys. Imaging Radiat. Oncol. 16, 61\u201368 (2020).","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"1152_CR200","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3171\/2016.8.SPINE16121","volume":"26","author":"KJ Redmond","year":"2017","unstructured":"Redmond, K. J. et al. Consensus guidelines for postoperative stereotactic body radiation therapy for spinal metastases: results of an international survey. J. Neurosurg. Spine 26, 299\u2013306 (2017).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR201","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/bioengineering10070872","volume":"10","author":"R Ghermandi","year":"2023","unstructured":"Ghermandi, R. et al. Carbon fiber-reinforced polyetheretherketone (CFR-PEEK) instrumentation in degenerative disease of lumbar spine: a pilot study. Bioengineering 10, 872 (2023).","journal-title":"Bioengineering"},{"key":"1152_CR202","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jocn.2020.03.013","volume":"75","author":"F Cofano","year":"2020","unstructured":"Cofano, F. et al. Carbon fiber reinforced vs titanium implants for fixation in spinal metastases: a comparative clinical study about safety and effectiveness of the new \u201ccarbon-strategy\u201d. J. Clin. Neurosci. 75, 106\u2013111 (2020).","journal-title":"J. Clin. Neurosci."},{"key":"1152_CR203","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1016\/j.prro.2024.10.011","volume":"15","author":"J Ward","year":"2025","unstructured":"Ward, J. et al. Use of magnetic resonance imaging for postoperative radiation therapy planning in patients with carbon fiber-reinforced polyetheretherketone instrumentation. Pract. Radiat. Oncol. 15, e131\u2013e137 (2025).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR204","first-page":"157S","volume":"15","author":"CA Alvarez-Breckenridge","year":"2025","unstructured":"Alvarez-Breckenridge, C. A. et al. Role of posterior carbon fiber implants in spine tumor surgery. Glob. Spine J. 15, 157S\u2013165S (2025).","journal-title":"Glob. Spine J."},{"key":"1152_CR205","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s007010050199","volume":"140","author":"J Klekamp","year":"1998","unstructured":"Klekamp, J. & Samii, H. Surgical results for spinal metastases. Acta Neurochir. 140, 957\u2013967 (1998).","journal-title":"Acta Neurochir."},{"key":"1152_CR206","doi-asserted-by":"publisher","first-page":"e531","DOI":"10.1016\/j.prro.2015.02.006","volume":"5","author":"ZD Epstein-Peterson","year":"2015","unstructured":"Epstein-Peterson, Z. D. et al. Postoperative radiation therapy for osseous metastasis: outcomes and predictors of local failure. Pract. Radiat. Oncol. 5, e531\u2013e536 (2015).","journal-title":"Pract. Radiat. Oncol."},{"key":"1152_CR207","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ijrobp.2016.03.027","volume":"95","author":"KJ Redmond","year":"2016","unstructured":"Redmond, K. J., Lo, S. S., Fisher, C. & Sahgal, A. Postoperativestereotactic body radiation therapy (SBRT) for spine metastases: a critical review to guide practice. Int. J. Radiat. Oncol. Biol. Phys. 95, 1414\u20131428 (2016).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"1152_CR208","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3171\/2015.6.SPINE15294","volume":"24","author":"MW Chan","year":"2016","unstructured":"Chan, M. W. et al. Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation. J. Neurosurg. Spine 24, 652\u2013659 (2016).","journal-title":"J. Neurosurg. Spine"},{"key":"1152_CR209","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.wneu.2010.06.037","volume":"74","author":"R Harel","year":"2010","unstructured":"Harel, R. et al. Spine instrumentation failure after spine tumor resection and radiation: comparing conventional radiotherapy with stereotactic radiosurgery outcomes. World Neurosurg. 74, 517\u2013522 (2010).","journal-title":"World Neurosurg."},{"key":"1152_CR210","first-page":"377","volume":"7","author":"LS Rosen","year":"2001","unstructured":"Rosen, L. S. et al. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. Cancer J. 7, 377\u2013387 (2001).","journal-title":"Cancer J."},{"key":"1152_CR211","first-page":"925","volume":"29","author":"TL Ng","year":"2021","unstructured":"Ng, T. L. et al. Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Support. Care Cancer 29, 925\u2013943 (2021).","journal-title":"Support. Care Cancer"},{"key":"1152_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2023.100470","volume":"39","author":"JP Lorange","year":"2023","unstructured":"Lorange, J. P. et al. Management of bone metastasis with zoledronic acid: a systematic review and Bayesian network meta-analysis. J. Bone Oncol. 39, 100470 (2023).","journal-title":"J. Bone Oncol."},{"key":"1152_CR213","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.21037\/apm.2019.08.07","volume":"9","author":"DN Desautels","year":"2020","unstructured":"Desautels, D. N., Harlos, C. H. & Jerzak, K. J. Role of bone-modifying agents in advanced cancer. Ann. Palliat. Med. 9, 1314\u20131323 (2020).","journal-title":"Ann. Palliat. Med."},{"key":"1152_CR214","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1177\/21925682231156394","volume":"14","author":"PP Patel","year":"2024","unstructured":"Patel, P. P. et al. Antiresorptive medications prior to stereotactic body radiotherapy for spinal metastasis are associated with reduced incidence of vertebral body compression fracture. Glob. Spine J. 14, 1778\u20131785 (2024).","journal-title":"Glob. Spine J."},{"key":"1152_CR215","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3171\/2025.3.SPINE231234","volume":"43","author":"KN Chou","year":"2025","unstructured":"Chou, K. N. et al. Vertebral fracture following primary stereotactic body radiation therapy for spinal bone metastases: a decade of experience. J. Neurosurg. Spine 43, 294\u2013304 (2025).","journal-title":"J. Neurosurg. Spine"}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01152-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01152-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01152-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T12:01:04Z","timestamp":1784721664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01152-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":215,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1152"],"URL":"https:\/\/doi.org\/10.1038\/s41571-026-01152-z","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"13 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.J.J. has acted as a consultant and\/or adviser of Amgen, AstraZeneca, Apo Biologix, BioCon, Daiichi Sankyo, Eli Lilly, Esai, Genomic Health, Gilead Sciences, Knight Therapeutics, Merck, Myriad Genetics, Novartis, Organon, Pfizer and Roche; and has received research support from AstraZeneca, BioCon, Eli Lilly, and Pfizer. A.\u00a0Sahgal has acted as a consultant and\/or adviser of AstraZeneca, BrainLab, CarboFIX, Cerapedics, Elekta AB, Seagen Inc, Servier and Varian; and has received research grants from BrainLab and Elekta AB and travel support from Elekta AB, BrainLab and Seagen. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}